NCT03045822View on ClinicalTrials.gov

BIA and Cardiac Implantable Electronic Devices

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 18, 2014

Primary Completion Date

February 28, 2016

Study Completion Date

January 16, 2017

Conditions
Performing Bioimpedance Analysis
Interventions
DRUG

Bioimpedance analysis

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT03045822 - BIA and Cardiac Implantable Electronic Devices | Biotech Hunter | Biotech Hunter